Hutchmed has continued to test sovleplenib in wAIHA in parallel, culminating in the delivery of data from a Chinese phase 3 ...

FDA clearance enables initiation of Abpro’s first clinical-stage solid tumor programClinical trial anticipated to commence in the first half of ...

One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San ...

In an era where scientific accuracy and reproducibility are paramount, the global antibody specificity testing market is ...

One of the hotter areas of cancer drug research involves using a particular type of bispecific antibody as the backbone for therapeutic combinations intended to bring a multi-pronged attack to tumors.

Introduction: Human cytomegalovirus (HCMV) induces severe morbidity and mortality in neonates, organ transplant recipients, and immunocompromised individuals. Currently, there is no licensed vaccine ...

CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Purple Biotech ( (PPBT)) has shared an ...

Twist Bioscience is advancing synthetic DNA manufacturing with innovation, expanding partnerships, and improving margins but remains at the lower end of its 52-week range. TWST is approaching ...